UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Annals of oncology, 2004-01, Vol.15 (1), p.129-133

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Annals of oncology, 2011-06, Vol.22 (6), p.1382-1391

2011

Link zum Volltext

Verfügbarkeit prüfen

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(−) EBV(−) HHV8(+) patient

European journal of haematology, 2013-11, Vol.91 (5), p.467-469

2013

Link zum Volltext

Verfügbarkeit prüfen

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Journal of cellular and molecular medicine, 2023-07, Vol.27 (14), p.1928-1946

2023

Link zum Volltext

Verfügbarkeit prüfen

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

British journal of haematology, 2003-05, Vol.121 (3), p.439-447

2003

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

British journal of haematology, 1999-10, Vol.107 (1), p.154-161

1999

Link zum Volltext

Verfügbarkeit prüfen

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Haematologica (Roma), 2021-07, Vol.106 (7), p.1923

2021

Link zum Volltext

Verfügbarkeit prüfen

Position paper on the therapeutic use of rituximab in CD20‐positive diffuse large B‐cell non‐Hodgkin's lymphoma

British journal of haematology, 2003-04, Vol.121 (1), p.44-48

2003

Link zum Volltext

Verfügbarkeit prüfen

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

British journal of haematology, 2008-11, Vol.143 (3), p.395-403

2008

Link zum Volltext

Verfügbarkeit prüfen

A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

European journal of haematology, 2001-01, Vol.66 (1), p.24-30

2001

Link zum Volltext

Verfügbarkeit prüfen

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

JAAD Case Reports, 2024-06, Vol.48, p.18-22

2024

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group

European journal of haematology, 2008-03, Vol.80 (3), p.227-235

2008

Link zum Volltext

Verfügbarkeit prüfen

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Cancer, 2010-11, Vol.116 (21), p.5001-5011

2010

Link zum Volltext

Verfügbarkeit prüfen

Burkitt‐like lymphoma with 11q aberration

Clinical case reports, 2019-09, Vol.7 (9), p.1823-1824

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

EJHaem, 2023-02, Vol.4 (1), p.108-114

2023

Link zum Volltext

Verfügbarkeit prüfen

Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries

British journal of haematology, 2022-02, Vol.196 (4), p.849-863

2022

Link zum Volltext

Verfügbarkeit prüfen

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Haematologica (Roma), 2011-07, Vol.96 (7), p.1002-1007

2011

Link zum Volltext

Verfügbarkeit prüfen

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Journal of medical case reports, 2020-09, Vol.14 (1), p.138-138, Article 138

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

European journal of haematology, 2006-09, Vol.77 (3), p.217-225

2006

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

Cancer, 2002-08, Vol.95 (3), p.576-580

2002

Link zum Volltext

Verfügbarkeit prüfen

Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non‐Hodgkin lymphoma

British journal of haematology, 2010-03, Vol.148 (5), p.808-810

2010

Link zum Volltext

Verfügbarkeit prüfen

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

European journal of haematology, 2007-02, Vol.78 (2), p.93-101

2007

Link zum Volltext

Verfügbarkeit prüfen

Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma

European journal of haematology, 2007-08, Vol.79 (2), p.150-154

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

Hematological oncology, 2011-03, Vol.29 (1), p.10-16

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(238)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(230)
Life Sciences & Biomedicine
(229)
Humans
(217)
Male
(157)
Female
(150)
Oncology
(141)
Middle Aged
(138)
Hematology
(136)
Adult
(125)
Aged
(115)
Lymphoma, Non-Hodgkin - Drug Therapy
(113)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(102)
Treatment Outcome
(84)
Biological And Medical Sciences
(81)
Medical Sciences
(81)
Prognosis
(70)
Adolescent
(67)
Cyclophosphamide - Administration & Dosage
(67)
Aggressive Lymphoma
(61)
Lymphoma, Non-Hodgkin - Mortality
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(−) EBV(−) HHV8(+) patient

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Position paper on the therapeutic use of rituximab in CD20‐positive diffuse large B‐cell non‐Hodgkin's lymphoma

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Burkitt‐like lymphoma with 11q aberration

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non‐Hodgkin lymphoma

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

Suchergebnisse filtern